1. 730PA pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis. (23rd October 2018) Authors: Yu, K; Mantha, S; Tjan, C; Kaufmann, E; Brenner, R B; Lowery, M; Ku, G; Raj, N; Shcherba, M; Goldberg, Z; Li, J; Zervoudakis, A; Hamilton, A; Won, E; Do, R K G; O'Reilly, E M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. (7th August 2012) Authors: Mantha, S; Karp, R; Raghavan, V; Terrin, N; Bauer, K A; Zwicker, J I Journal: BMJ Issue: Volume 345(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. New Avenues for Anticoagulation in Atrial Fibrillation. Issue 1 (5th December 2012) Authors: Mantha, S; Cabral, K; Ansell, J Journal: Clinical pharmacology & therapeutics Issue: Volume 93:Issue 1(2013) Page Start: 68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗